Atlas of Clinical Neurology

Front Cover
Roger N. Rosenberg
Springer Science & Business Media, Feb 8, 2012 - Medical - 560 pages
0 Reviews
The newly revised, comprehensive, four-color Atlas of Clinical Neurology is extensively updated with reference to current literature. The new third edition organizes the highest-quality images from the field of clinical neurology, including clinical syndromes, for neurologists and clinicians. The atlas highlights the enormous strides being made in the biologic understanding of neurologic disease, covering developmental and genetic diseases, neuroendocrine disorders, critical care neurology, cerebrovascular disease, dementias, behavioral neurology, neuro-oncology, movement disorders, epilepsy, neuromuscular diseases, infectious diseases, neuroimmunology, neurotoxic disorders, and headache. This indispensable collection contains over 1300 images including algorithms, tables, charts, and schematic drawings.

What people are saying - Write a review

We haven't found any reviews in the usual places.


Chapter 1 Developmental Disorders
Chapter 2 Genetic Diseases of the Nervous System
Chapter 3 Neuroendocrine Disorders
Chapter 4 Critical Care Neurology
Chapter 5 Cerebrovascular Disease
Chapter 6 Dementias
Chapter 7 Behavioral Neurology
Chapter 8 Neurooncology
Chapter 10 The Epilepsies
Chapter 11 Neuromuscular Disease
Chapter 12 Infectious Diseases of the Nervous System
Chapter 13 Neuroimmunology
Chapter 14 Neurotoxic Disorders
Chapter 15 Headache

Chapter 9 Movement Disorders

Other editions - View all

Common terms and phrases

About the author (2012)

Roger N. Rosenberg, MD holds the Abe (Brunky), Morris and William Zale Distinguished Chair and Professor of Neurology, University of Texas Southwestern Medical Center at Dallas. He served as Chair of the Department of Neurology from 1973- 1991. He is the founding Director of the NIH funded Alzheimer's Disease Center at UT Southwestern and it has been funded through five consecutive competitive funding cycles since 1988 and will be funded through 2016 representing 27 years of continuous NIH Center funding. He is certified by the American Board of Psychiatry and Neurology. He served as Chief Resident in Neurology to H. Houston Merritt, MD, Neurological Institute, Columbia University Medical Center, New York, 1967-1968. He was a Post-Doctoral Research Fellow for Marshall Nirenberg, PhD, Laboratory of Biochemical Genetics, National Institutes of Health, 1968-1970.
Dr. Rosenberg has received important honors and awards including the prestigious UT Chancellor's Discovery Lecture, invited by Chancellor Francisco Cigarroa for the Chancellor's Council Meeting and Symposium, the University of Texas System, 2013. The Discovery Lecture was: "DNA A?42 Vaccination as Therapy for Alzheimer's Disease?. He was awarded the World Federation of Neurology, 1st Science Medal for Scientific Achievements in Neurology and Neuroscience, presented at the World Congress of Neurology in Bangkok, Thailand in 2009.
He is an Honorary Member (Elected) of the American Neurological Association, 2006 and the American Academy of Neurology 1997.
He received the Nancy R. McCune Research Award of the Alzheimer's Association (AWARE) (2005).
He was the Robert Wartenberg Lecturer of the American Academy of Neurology, 2000, and his lecture was "The Molecular and Genetic Basis of Alzheimer's Disease?.
He is an elected Honorary Member, Spanish Neurological Society, 1994. He was awarded the 1st Distinguished Neurology Alumnus Award of the Neurological Institute; Columbia University Medical Center; 1994.
He has been the Editor in Chief, JAMA Neurology (1997- present) and a member of the Editorial Board of JAMA (1997-present).
He was elected a Fellow, American Association for the Advancement of Science, February 1991
He was elected President of the American Academy of Neurology (1991-1993) and
1st Vice President of the American Neurological Association (1988-89). He received the Northwestern University Medical School Alumni Association Merit Award (1986).
In 2006, he published for the first time that a DNA A ?42 vaccine administered with the gene gun method into the skin of Alzheimer disease model mice can reduce A?42 peptide levels in the brain by 50% with anti-A ?42 antibody of the IgG1/Th2 type which is known to be anti-inflammatory. He received in 2009 a US Patent as Inventor of "Amyloid ? Gene Vaccines?. This DNA vaccine has the potential to be a safe and effective therapy to prevent Alzheimer disease.
He described Machado-Joseph disease (MJD), an autosomal dominant ataxia, with William Nyhan, M.D. Ph.D, in 1976, for the first time. MJD is now the most common autosomal domiant spinocerebellar ataxia world-wide.
Dr. Rosenberg has published over 270 original scientific papers, chapters, reviews and editorials. He is the founding editor and senior editor since 1993 for all five editions of "The Molecular and Genetic Basis of Neurological and Psychiatric Diseases?.

Bibliographic information